Strategic Partnerships Arbutus Biopharma has recently entered a significant global settlement with Moderna, which could result in payments up to 2.5 billion dollars, indicating strong industry collaborations and potential for further licensing or partnership opportunities.

Focus on Hepatitis B The company's Core focus on developing innovative therapeutics for chronic hepatitis B virus positions them as a key player in infectious disease treatment, creating opportunities to offer advanced delivery platforms and complementary technologies.

Active Industry Presence Participation in major conferences like AASLD and EASL Congress and the launch of a scientific advisory board demonstrate ongoing engagement with scientific communities, opening avenues for sales of research tools, clinical trial support services, and strategic consulting.

Emerging Revenue With annual revenues between 10 to 25 million dollars and a focus on proprietary RNAi therapeutics, there is potential to expand project pipelines and secure investment in related biotech tools, lab equipment, or manufacturing services.

Technology Utilization Utilizing advanced tech stack like Backbone.js, JSON-LD, and Akamai suggests a robust digital infrastructure, indicating opportunities to provide digital solutions, data analytics, or security services to support their research and operational needs.